X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (235) 235
index medicus (138) 138
female (126) 126
male (123) 123
hiv infections - drug therapy (122) 122
infectious diseases (112) 112
1-infected patients (111) 111
immunology (96) 96
hiv (91) 91
adult (83) 83
hiv infections - immunology (74) 74
child (73) 73
viral load (70) 70
1-infected children (69) 69
hiv infections - virology (65) 65
virology (65) 65
antiretroviral therapy, highly active (58) 58
human-immunodeficiency-virus (57) 57
anti-hiv agents - therapeutic use (56) 56
hiv infection (54) 54
adolescent (53) 53
middle aged (53) 53
health aspects (52) 52
active antiretroviral therapy (51) 51
antiretroviral therapy (51) 51
antiviral agents (51) 51
cd4 lymphocyte count (46) 46
highly active antiretroviral therapy (45) 45
pharmacology & pharmacy (43) 43
1-infected individuals (42) 42
hiv-1 - drug effects (42) 42
child, preschool (41) 41
hiv-1 (40) 40
hiv-1 - genetics (40) 40
aids (38) 38
treatment outcome (38) 38
children (37) 37
drug therapy, combination (36) 36
research (35) 35
microbiology (34) 34
virus diseases (33) 33
disease progression (31) 31
drug therapy (31) 31
hiv-1-infected children (31) 31
human immunodeficiency virus--hiv (31) 31
infection (31) 31
care and treatment (30) 30
protease inhibitors (30) 30
genotype (29) 29
pediatrics (29) 29
immunodeficiency-virus type-1 (28) 28
hiv-1 - immunology (27) 27
infant (26) 26
therapy (26) 26
hiv-1-infected patients (25) 25
hiv patients (24) 24
risk factors (24) 24
drug resistance, viral (23) 23
t cells (23) 23
antiretroviral drugs (22) 22
cohort studies (22) 22
combination therapy (22) 22
hiv infections - complications (22) 22
lymphocytes (22) 22
viruses (22) 22
aged (21) 21
drug-resistance (21) 21
gastroenterology & hepatology (21) 21
research article (21) 21
rna, viral - blood (21) 21
cd4-positive t-lymphocytes - immunology (20) 20
hepatitis c (20) 20
hepatitis c virus (20) 20
time factors (20) 20
haart (19) 19
treatment failure (19) 19
anti-hiv agents - pharmacology (18) 18
drug resistance (18) 18
hiv-infection (18) 18
analysis (17) 17
antiviral agents - therapeutic use (17) 17
flow cytometry (17) 17
genotype 1-infected patients (17) 17
hiv-1 infection (17) 17
hiv-infected children (17) 17
infected patients (17) 17
mutation (17) 17
young adult (17) 17
acquired immune deficiency syndrome--aids (16) 16
anti-hiv agents - administration & dosage (16) 16
cd8-positive t-lymphocytes - immunology (16) 16
drug resistance, viral - genetics (16) 16
hiv infections - transmission (16) 16
human immunodeficiency virus (16) 16
immune reconstitution (16) 16
medicine (16) 16
molecular sequence data (16) 16
aids/hiv (15) 15
hepacivirus - genetics (15) 15
infections (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Dietz, Julia and Susser, Simone and Vermehren, Johannes and Peiffer, Kai-Henrik and Grammatikos, Georgios and Berger, Annemarie and Ferenci, Peter and Buti, Maria and Müllhaupt, Beat and Hunyady, Bela and Hinrichsen, Holger and Mauss, Stefan and Petersen, Jörg and Buggisch, Peter and Felten, Gisela and Hüppe, Dietrich and Knecht, Gaby and Lutz, Thomas and Lutz, U and Schott, Eckart and Schott, E and Berg, Thomas and Berg, C and Berg, Christoph and Spengler, Ulrich and von Hahn, Thomas and Zeuzem, Stefan and Sarrazin, Christoph and Antoni, C and Vogelmann, R and Ebert, M and Backhus, J and Seufferlein, T and Balavoine, J and Giostra, E and Cornberg, M and Wedemeyer, H and Manns, M and De Gottardi, A and Esteban, R and Discher, T and Roeb, E and Gress, M and Günther, R and Wietzke-Braun, P and Herrmann, A and Stallmach, A and Hoffmann, D and Klinker, H and Kodal, A and Lammert, F and Löbermann, M and Schulze zur Wiesch, J and von Felden, J and Piecha, F and Lohse, A and Götze, T and Malfertheiner, P and Mayerle, J and Moradpour, D and Moreno, C and Neumann-Haefelin, C and Thimme, R and Reinhardt, L and Ellenrieder, V and Schattenberg, J and Sprinzl, M and Galle, P and Schmidt, W and Schmidt, J and Epple, H.-J and Siebler, J and Stauber, R and Steckstor, M and Schmiegel, W and Stremmel, W and Strey, B and Tomasiewicz, K and Trautwein, C and Zachoval, R and Angeli, W and Beckebaum, S and Doberauer, C and Ende, K and Erhardt, A and Garrido-Lüneburg, A and Gattringer, H and Genné, D and Gschwantler, M and Gundling, F and Hartmann, C and Heyer, T and Hirschi, C and Kanzler, S and Kordecki, N and Kraus, M and Kullig, U and Magenta, L and Terziroli Beretta-Piccoli, B and Menges, M and ... and European HCV Resistance Study Grp and European HCV Resistance Study Group
Gastroenterology, ISSN 0016-5085, 03/2018, Volume 154, Issue 4, pp. 976 - 988.e4
Journal Article
Aging, ISSN 1945-4589, 06/2019, Volume 11, Issue 11, pp. 3864 - 3875
In our previous study, we found that low thymic output and short telomere length were associated with a higher risk of tumor in elderly cancer patients. Here,... 
Immune senescence | Inflammation/immune activation | Elderly | Colorectal cancer | colorectal cancer | MEMORY | inflammation/immune activation | elderly | INFLAMMATION | MICROBIOTA | 1-INFECTED CHILDREN | CYTOMEGALOVIRUS | immune senescence | CELL BIOLOGY | GERIATRICS & GERONTOLOGY
Journal Article
Seminars in Liver Disease, ISSN 0272-8087, 07/2019, Volume 39, Issue 3, pp. 354 - 368
Journal Article
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 01/2012, Volume 12, Issue 1, pp. 14 - 14
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 4/2018, Volume 53, Issue 4, pp. 548 - 556
In Japan, daclatasvir (DCV) and asunaprevir (ASV) therapy was the first IFN-free treatment to be approved, and thousands of patients have since been... 
Ledipasvir/sofosbuvir with ribavirin | NS5A inhibitor | Daclatasvir | Retreatment | Medicine & Public Health | Resistance-associated variants | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Asunaprevir | Surgical Oncology | NS5B polymerase inhibitor | SOFOSBUVIR | DACLATASVIR PLUS ASUNAPREVIR | LEDIPASVIR | VIRUS PATIENTS | DUAL THERAPY | COMBINATION TREATMENT | CHRONIC HCV INFECTION | 1-INFECTED PATIENTS | INHIBITOR | GASTROENTEROLOGY & HEPATOLOGY | GENOTYPE 1B INFECTION | Humans | Middle Aged | Fluorenes - therapeutic use | Hepatitis C, Chronic - virology | Male | RNA, Viral - blood | Treatment Failure | Aged, 80 and over | Female | Fluorenes - adverse effects | Uridine Monophosphate - adverse effects | Imidazoles - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Uridine Monophosphate - therapeutic use | Hepacivirus - isolation & purification | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Pilot Projects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Isoquinolines - therapeutic use | Aged | Retreatment - methods | Sustained Virologic Response | Retreatment - adverse effects | Medicine, Experimental | Medical research | Care and treatment | Hepatitis C | Hepatitis C virus | Ribavirin | Cirrhosis | Hepatitis | Liver | Interferon | Ribonucleic acid--RNA | Patients
Journal Article
Journal Article
Experimental Gerontology, ISSN 0531-5565, 12/2013, Volume 48, Issue 12, pp. 1436 - 1442
Journal Article